Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CNSystems announces new CEO

This article was originally published in Clinica

Executive Summary

CNSystems (Graz, Austria), which markets the CNAP a continuous, non invasive blood pressure management system, has appointed Paul Krell to the position of CEO. Mr Krell joins from Abiomed Europe (blood pumps for use in coronary surgery), where he was general manager for Europe. Prior to this he was vice-president for Europe at ev3's neurovascular division. He has more than 16 years' experience in the medical device industry, including nine years at Guidant in managerial roles, including as country manager for Germany (cardiac surgery products). Mr Krell succeeds Jürgen Fortin, the company's founder and CEO. Mr Fortin will continue as chief scientific officer and will focus on expanding the firm's technology portfolio and potential markets.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel